Skip to main content

Your search for “Inflammation” returned 378 results

UC San Diego Receives $12.4M NIH Grant to Map the Human Nervous System

February 23, 2022

The National Institutes of Health have awarded UC San Diego a grant totaling $12.4 million. This will support a new research center dedicated to studying the human brain and central nervous system 〈CNS〉, specifically the ways they’re affected by HIV and opioids.

Cancer Cells Co-opt Immune Response to Escape Destruction

December 18, 2012

Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth.

Drug Treatment Corrects Autism Symptoms in Mouse Model

March 13, 2013

Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego School of Medicine have used a newly discovered function of an old drug to restore cell communications in a mouse model of autism, reversing symptoms of the devastating disorder.

Kids With MIS-C Mount Normal T Cell Response to COVID-19

October 7, 2021

UC San Diego study suggests multisystem inflammatory syndrome in children (MIS-C), a rare condition associated with COVID-19, is not caused by abnormal T cell response to COVID-19 virus as previously hypothesized.

Neutrophil Nanosponges Soak up Proteins That Promote Rheumatoid Arthritis

September 3, 2018

Engineers have developed neutrophil “nanosponges” that can safely absorb and neutralize a variety of proteins that play a role in the progression of rheumatoid arthritis. Injections of these nanosponges effectively treated severe rheumatoid arthritis in two mouse models. Administering the nanosponges early on also prevented the disease from developing. The…

Bariatric Surgery Decreases Risk of Uterine Cancer

March 24, 2014

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center report that bariatric surgery resulting in dramatic weight loss in formerly severely obese women reduces the risk of endometrial (uterine) cancer by 71 percent and as much as 81 percent if normal weight is maintained…

Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation

June 8, 2021

Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.

Pictured Together for the First Time: a Chemokine and its Receptor

January 22, 2015

Researchers at University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences and the Bridge Institute at the University of Southern California report the first crystal structure of the cellular receptor CXCR4 bound to an immune signaling protein called a chemokine. The structure answers longstanding questions about a…

Scripps Professor Receives Research Achievement Award

February 18, 2016

Scripps Institution of Oceanography at UC San Diego Distinguished Professor William Gerwick received the American Society of Pharmacognosy’s Norman R. Farnsworth Research Achievement Award for his outstanding contributions to natural products research. Gerwick will accept the award during the Society’s annual meeting in July at the 2016 Joint Natural Products Conference in Copenhagen.

UC San Diego Cancer Researchers Receive NCI Outstanding Investigator Award

August 28, 2015

Four University of California, San Diego School of Medicine researchers have been selected to receive the newly established National Cancer Institute (NCI) Outstanding Investigator Award. The multi-million dollar awards fund new projects that have an unusual potential in cancer research over seven years.

Category navigation with Social links